This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Shanghai Escugen Biotechnology Co., Ltd., Shanghai Escugen Biotechnology Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations of Xinmin Zhang in Antibody Development
Introduction
Xinmin Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the creation of a unique single-domain antibody that targets human CD47.
Latest Patents
Xinmin Zhang holds 1 patent for his invention titled "Human CD47-targeting single-domain antibody and use thereof." This patent relates to an anti-CD47 single-domain antibody and its applications, as well as a method for preparing the antibody. The single-domain antibody comprises a complementarity-determining region (CDR) selected from specific sequences, which enhances its effectiveness in targeting CD47.
Career Highlights
Xinmin Zhang is currently associated with Shanghai Escugen Biotechnology Co., Ltd. His work at this company focuses on advancing biotechnological solutions that can have a profound impact on medical treatments. His expertise in antibody development has positioned him as a key figure in the industry.
Collaborations
Xinmin Zhang collaborates with talented professionals in his field, including Xiangyu He and Weihong Nian. These collaborations foster innovation and contribute to the advancement of biotechnological research.
Conclusion
Xinmin Zhang's contributions to the field of biotechnology, particularly through his patented innovations, highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and antibody development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile